Deep, qualified future-generation sequencing has unveiled that subclonal mutations (i.e., those current in just a portion of tumor cells) could be detected for all driver genes and are connected with speedy disease development and inadequate final result.eleven–13 This is especially appropriate for TP53 mutations specified The point that, as defi